Agenus, Inc. - Product Pipeline Review - 2016

TELEPHONE: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com

Report Overview
‘Agenus, Inc. - Product Pipeline Review - 2016’, provides an overview of the Agenus, Inc.’s
pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by
Agenus, Inc., complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete research and development
history and the dormant and discontinued projects.
Report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from
proprietary databases, company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from company/university sites and
industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the
latest set of information. Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
Read More At: http://www.researchbeam.com/agenus-inc-product-pipeline-review-2016-market

Report Overview
Scope
• The report provides a snapshot of the pipeline therapeutic landscape of Agenus, Inc.
• The report provides overview of Agenus, Inc. including its business description, key facts, and
locations and subsidiaries
• The report covers pipeline products based on various stages of development ranging from preregistration
till discovery and undisclosed stages
• The report assesses Agenus, Inc.’s pipeline therapeutics based on drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type
Reasons to buy
• Evaluate Agenus, Inc.’s strategic position with total access to detailed information on its product
pipeline
• Identify emerging players with potentially strong product portfolio and create effective counterstrategies
to gain competitive advantage
• Identify important and diverse types of therapeutics under development for Agenus, Inc.
• Identify potential new clients or partners in the target demographic
• acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Read More At: http://www.researchbeam.com/agenus-inc-product-pipeline-review-2016-market

Table of Content
List of Figures
Agenus, Inc. - Pipeline by Top 10 Indication, 2016 9
Agenus, Inc. - Pipeline by Stage of Development, 2016 11
Agenus, Inc. - Monotherapy Products in Pipeline, 2016 12
Agenus, Inc. - Partnered Products in Pipeline, 2016 13
Agenus, Inc. - Out-Licensed Products in Pipeline, 2016 15
Agenus, Inc. - Pipeline by Top 10 Target, 2016 33
Agenus, Inc. - Pipeline by Top 10 Molecule Type, 2016 35
Agenus, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016 36
Enquire At : http://www.researchbeam.com/agenus-inc-product-pipeline-review-2016-market/enquireabout-report

FOR MORE DETAILS
Visit us at :
http://www.researchbeam.com/agenus-inc-product-pipeline-review-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States